Transgenomic buys Clinical Data markers

Transgenomic has struck a deal to buy Clinical Data's genetic tests for heart disease along with the biomarkers needed for the PGxPredict tests for $15.4 million. The deal provides $6 million upfront with the rest in one-year and three-year promissory notes. Report